These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Successful treatment of aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease. Saulsbury FT. Clin Infect Dis; 2001 May 15; 32(10):E137-9. PubMed ID: 11317265 [Abstract] [Full Text] [Related]
3. Successful treatment of cerebral aspergillosis with a high oral dose of itraconazole after excisional surgery. Imai T, Yamamoto T, Tanaka S, Kashiwagi M, Chiba S, Matsumoto H, Uede T. Intern Med; 1999 Oct 15; 38(10):829-32. PubMed ID: 10526950 [Abstract] [Full Text] [Related]
4. Preoperative antifungal therapy may improve survival in patients with Aspergillus brain abscess. Wasay M, Patel J, Azam I, Khan MA, Smego RA. Clin Neurol Neurosurg; 2009 Sep 15; 111(7):565-7. PubMed ID: 19328623 [Abstract] [Full Text] [Related]
5. Itraconazole in the treatment of orbital aspergillosis. Massry GG, Hornblass A, Harrison W. Ophthalmology; 1996 Sep 15; 103(9):1467-70. PubMed ID: 8841307 [Abstract] [Full Text] [Related]
6. Triazole Resistance Is Still Not Emerging in Aspergillus fumigatus Isolates Causing Invasive Aspergillosis in Brazilian Patients. Negri CE, Gonçalves SS, Sousa ACP, Bergamasco MD, Martino MDV, Queiroz-Telles F, Aquino VR, Castro PTO, Hagen F, Meis JF, Colombo AL. Antimicrob Agents Chemother; 2017 Nov 15; 61(11):. PubMed ID: 28893772 [Abstract] [Full Text] [Related]
7. Successful treatment of cerebral aspergillosis by stereotactic operation and antifungal therapy. Kerkmann ML, Blaschke-Hellmessen R, Mikulin HD. Mycoses; 1994 Nov 15; 37(3-4):123-6. PubMed ID: 7845417 [Abstract] [Full Text] [Related]
10. Treatment of invasive aspergillosis with itraconazole. Denning DW, Tucker RM, Hanson LH, Stevens DA. Am J Med; 1989 Jun 15; 86(6 Pt 2):791-800. PubMed ID: 2543220 [Abstract] [Full Text] [Related]
11. Neuroaspergillosis and brain tuberculosis in an immunocompetent patient with good outcome. Renard JE, Onnient Y, Proust F, Massardier E, Raspaud C, Nouvet G, Brasseur P, Humbert G, Mihout B. J Neurol Neurosurg Psychiatry; 1998 Mar 15; 64(3):411-2. PubMed ID: 9527169 [No Abstract] [Full Text] [Related]
12. Itraconazole for the treatment of pulmonary aspergillosis in heart transplant recipients. Nanas JN, Saroglou G, Anastasiou-Nana MI, Kostis EB, Petrochilou-Paschou VP, Kontoyannis DA, Stamatelopoulos SF, Moulopoulos SD. Clin Transplant; 1998 Feb 15; 12(1):30-4. PubMed ID: 9541420 [Abstract] [Full Text] [Related]
13. Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B. Kontoyiannis DP, Andersson BS, Lewis RE, Raad II. Clin Infect Dis; 2001 Mar 01; 32(5):E94-6. PubMed ID: 11229866 [Abstract] [Full Text] [Related]
14. Multidrug resistance in Aspergillus fumigatus. Warris A, Weemaes CM, Verweij PE. N Engl J Med; 2002 Dec 26; 347(26):2173-4. PubMed ID: 12501236 [No Abstract] [Full Text] [Related]
15. Mixed infection with itraconazole-susceptible and-resistant strains of Aspergillus fumigatus: Diagnostic and therapeutic implications. Ahmad S, Khan Z. J Infect Public Health; 2020 Apr 26; 13(4):664-666. PubMed ID: 32171723 [No Abstract] [Full Text] [Related]
18. Cerebral aspergillosis: long term efficacy and safety of liposomal amphotericin B in kidney transplant. Carlini A, Angelini D, Burrows L, De Quirico G, Antonelli A. Nephrol Dial Transplant; 1998 Oct 26; 13(10):2659-61. PubMed ID: 9794583 [No Abstract] [Full Text] [Related]